Sartorius Posts 51% Profit Jump, Reaffirms Fiscal 2026 Guidance

German pharmaceutical and lab equipment maker Sartorius AG (SARTF, SRT.DE) reported Thursday that net profit for the first nine months of fiscal 2026 rose 51 percent to 188.3 million euros ($205 million) from 124.7 million euros a year earlier, driven by sales growth. Underlying net profit increased 6.7 percent to 259.8 million euros, with underlying earnings per ordinary share of 3.76 euros versus 3.52 euros last year. Group underlying EBITDA rose 6.9 percent to 828 million euros, lifting the margin 0.5 percentage points to 30.2 percent. Sales revenue climbed 4.9 percent to 2.737 billion euros, while operational sales grew 8.1 percent in constant currencies, led by recurring consumables business. The company reaffirmed its fiscal 2026 outlook, expecting constant-currency operational sales growth near the midpoint of its 5 to 9 percent range and an underlying EBITDA margin slightly above 30 percent. Separately, Sartorius named Alexandra Gatzemeyer Chief Commercial Officer and René Fáber Chief Product Officer effective January 1, 2027.